PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SBIO.L vs. BOTZ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between SBIO.L and BOTZ is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

SBIO.L vs. BOTZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
-5.71%
10.28%
SBIO.L
BOTZ

Key characteristics

Sharpe Ratio

SBIO.L:

0.27

BOTZ:

0.65

Sortino Ratio

SBIO.L:

0.48

BOTZ:

1.02

Omega Ratio

SBIO.L:

1.06

BOTZ:

1.12

Calmar Ratio

SBIO.L:

0.20

BOTZ:

0.47

Martin Ratio

SBIO.L:

0.80

BOTZ:

2.54

Ulcer Index

SBIO.L:

6.20%

BOTZ:

5.53%

Daily Std Dev

SBIO.L:

18.38%

BOTZ:

21.69%

Max Drawdown

SBIO.L:

-39.44%

BOTZ:

-55.54%

Current Drawdown

SBIO.L:

-15.02%

BOTZ:

-13.32%

Returns By Period

In the year-to-date period, SBIO.L achieves a 6.12% return, which is significantly lower than BOTZ's 7.45% return.


SBIO.L

YTD

6.12%

1M

5.24%

6M

-6.19%

1Y

4.44%

5Y*

3.84%

10Y*

2.95%

BOTZ

YTD

7.45%

1M

3.94%

6M

8.50%

1Y

15.29%

5Y*

9.33%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SBIO.L vs. BOTZ - Expense Ratio Comparison

SBIO.L has a 0.40% expense ratio, which is lower than BOTZ's 0.68% expense ratio.


BOTZ
Global X Robotics & Artificial Intelligence Thematic ETF
Expense ratio chart for BOTZ: current value at 0.68% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.68%
Expense ratio chart for SBIO.L: current value at 0.40% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.40%

Risk-Adjusted Performance

SBIO.L vs. BOTZ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBIO.L
The Risk-Adjusted Performance Rank of SBIO.L is 1212
Overall Rank
The Sharpe Ratio Rank of SBIO.L is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of SBIO.L is 1212
Sortino Ratio Rank
The Omega Ratio Rank of SBIO.L is 1212
Omega Ratio Rank
The Calmar Ratio Rank of SBIO.L is 1313
Calmar Ratio Rank
The Martin Ratio Rank of SBIO.L is 1212
Martin Ratio Rank

BOTZ
The Risk-Adjusted Performance Rank of BOTZ is 2323
Overall Rank
The Sharpe Ratio Rank of BOTZ is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of BOTZ is 2222
Sortino Ratio Rank
The Omega Ratio Rank of BOTZ is 2222
Omega Ratio Rank
The Calmar Ratio Rank of BOTZ is 2222
Calmar Ratio Rank
The Martin Ratio Rank of BOTZ is 2727
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SBIO.L vs. BOTZ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SBIO.L, currently valued at 0.03, compared to the broader market0.002.004.000.030.49
The chart of Sortino ratio for SBIO.L, currently valued at 0.16, compared to the broader market-2.000.002.004.006.008.0010.0012.000.160.80
The chart of Omega ratio for SBIO.L, currently valued at 1.02, compared to the broader market0.501.001.502.002.503.001.021.10
The chart of Calmar ratio for SBIO.L, currently valued at 0.02, compared to the broader market0.005.0010.0015.000.020.35
The chart of Martin ratio for SBIO.L, currently valued at 0.08, compared to the broader market0.0020.0040.0060.0080.00100.000.081.87
SBIO.L
BOTZ

The current SBIO.L Sharpe Ratio is 0.27, which is lower than the BOTZ Sharpe Ratio of 0.65. The chart below compares the historical Sharpe Ratios of SBIO.L and BOTZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
0.03
0.49
SBIO.L
BOTZ

Dividends

SBIO.L vs. BOTZ - Dividend Comparison

SBIO.L has not paid dividends to shareholders, while BOTZ's dividend yield for the trailing twelve months is around 0.13%.


TTM202420232022202120202019201820172016
SBIO.L
Invesco Nasdaq Biotech UCITS ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BOTZ
Global X Robotics & Artificial Intelligence Thematic ETF
0.13%0.13%0.20%0.23%0.16%0.19%0.83%1.44%0.01%0.06%

Drawdowns

SBIO.L vs. BOTZ - Drawdown Comparison

The maximum SBIO.L drawdown since its inception was -39.44%, smaller than the maximum BOTZ drawdown of -55.54%. Use the drawdown chart below to compare losses from any high point for SBIO.L and BOTZ. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%SeptemberOctoberNovemberDecember2025February
-15.02%
-13.32%
SBIO.L
BOTZ

Volatility

SBIO.L vs. BOTZ - Volatility Comparison

The current volatility for Invesco Nasdaq Biotech UCITS ETF (SBIO.L) is 5.22%, while Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ) has a volatility of 6.92%. This indicates that SBIO.L experiences smaller price fluctuations and is considered to be less risky than BOTZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%10.00%SeptemberOctoberNovemberDecember2025February
5.22%
6.92%
SBIO.L
BOTZ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab